Huberman Lab Understanding & Healing the Mind | Dr. Karl Deisseroth
154 snips
Jun 28, 2021 
Dr. Karl Deisseroth, a clinical psychiatrist and Stanford bioengineering lab director, shares his groundbreaking work in mental health. He discusses innovations like optogenetics, offering hope for conditions from ADHD to schizophrenia. Karl reveals the importance of personal connections in therapy and how insights from psychedelics could transform treatment paradigms. He also highlights the vital relationship between brain structure and mental health, emphasizing the need for tailored approaches to psychiatric care.
AI Snips
Chapters
Books
Transcript
Episode notes
Autism and Fever
- Anecdotal reports suggest autistic children's symptoms improve with fever, possibly due to altered brain activity.
- Deisseroth acknowledges the difficulty of studying this quantitatively.
Channelopsins and Optogenetics
- Channelopsins, light-sensitive proteins from algae, can control neuron activity.
- This technology, optogenetics, allows precise manipulation of brain circuits.
Restoring Vision with Channelopsins
- Deisseroth's colleague, Botan Roska, used channelopsins to help a blind person see light.
- This milestone followed a decade of research and clinical development.
